WallStreetZenWallStreetZen

NASDAQ: VVOS
Vivos Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Vivos Therapeutics earnings were -$14.3M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest VVOS earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$5.0M, up 29.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, VVOS reported annual earnings of -$11.1M, with -18% growth.

VVOS earnings history

Current Revenue
$14.4M
Current Earnings
-$14.3M
Current Profit Margin
-99.5%

VVOS Return on Equity

Current Company
-232.8%
Current Industry
15.2%
Current Market
32.2%
VVOS's Return on Equity (-232.8%)... subscribe to Premium to read more.
High Return on Equity Performance

VVOS undefined

Current Company
-84.3%
Current Industry
8.9%
VVOS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when VVOS announces earnings.

VVOS undefined

Current Company
-73.04%
Current Industry
10.6%
VVOS has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VVOS vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
VVOS-$13.55M-$14.32MN/A-$1.68
NMTC-$4.97M-$5.34MN/A-$0.15
RBOT-$56.85M-$59.63MN/A-$10.08
MYO-$7.41M-$9.32MN/A-$0.22
MODD-$19.74M-$21.39MN/A-$0.51
View Top Medical Device Stocks

Vivos Therapeutics Earnings Reports & History FAQ

What were Vivos Therapeutics's earnings last quarter?

On VVOS's earnings call on Invalid Date, Vivos Therapeutics (NASDAQ: VVOS) reported Q2 2025 earnings per share (EPS) of -$0.55, up 8.33% year over year. Total VVOS earnings for the quarter were -$5.01 million. In the same quarter last year, Vivos Therapeutics's earnings per share (EPS) was -$0.60.

If you're new to stock investing, here's how to buy Vivos Therapeutics stock.

Is Vivos Therapeutics profitable or losing money?

As of the last Vivos Therapeutics earnings report, Vivos Therapeutics is currently losing money. Vivos Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$14.32 million, a 18.89% increase year over year.

What was VVOS's earnings growth in the past year?

As of Vivos Therapeutics's earnings date in Invalid Date, Vivos Therapeutics's earnings has grown year over year. VVOS earnings in the past year totalled -$14.32 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.